BIOTRANSFORMATION AND EXCRETION OF LORAZEPAM IN PATIENTS WITH CHRONIC RENAL-FAILURE

被引：58

作者：

VERBEECK, R

TJANDRAMAGA, TB

VERBERCKMOES, R

DESCHEPPER, PJ

机构：

[1] CATHOLIC UNIV LEUVEN,DEPT PHARMACOL,DIV CLIN PHARMACOL,B-3030 HEVERLE,BELGIUM

[2] CATHOLIC UNIV LEUVEN,DEPT MED,DIV CLIN PHARMACOL,B-3030 HEVERLE,BELGIUM

来源：

关键词：

D O I：

10.1111/j.1365-2125.1976.tb00354.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1033 / 1039

页数：7

共 10 条

[1]

de Silva J A, 1973, J Chromatogr Sci, V11, P547

[2]

GLUCKMAN MI, 1971, ARZNEI-FORSCHUNG, V21, P1049

HAIDER, I .

[4]

KNOWLES JA, 1971, ARZNEI-FORSCHUNG, V21, P1055

[5] WY 4036 (LORAZEPAM) - ITS USE IN PREMEDICATION [J].

NORRIS, W ;

WALLACE, PGM .

[6]

OLGIATI SG, 1975, CURR THER RES CLIN E, V17, P13

[7]

OWEN G, 1971, ARZNEI-FORSCHUNG, V21, P1065

[8]

SCHILLINGS RT, 1971, ARZNEI-FORSCHUNG, V21, P1059

[9]

SCHILLINGS RT, 1975, 5393 WYETH GEN TECHN

[10]

SHERLIKER J, 1973, CURR MED RES OPIN, V1, P308